DOCSLIB.ORG

GLP Compliance Monitoring Programme As of 18 January 2021

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Laboratories that are members of the UK GLP Compliance Monitoring Programme as of 18 January 2021 The following list includes full members of the Compliance Programme that have been inspected and issued with a Statement of GLP Compliance as well as prospective members that are awaiting an implementation inspection. If a test facility is not present on the list, please contact the GLPMA at [email protected] for clarification of a facility’s status. The GLPMA can also provide guidance regarding whether a test facility has historically been a member of the UK compliance monitoring programme. Version 6.0 18 January 2021 Full members of the GLP compliance monitoring programme AGROCHEMEX ENVIRONMENTAL Aldhams Farm Research Centre Dead Lane Lawford, Manningtree Essex CO11 2NF AGROCHEMEX INTERNATIONAL LIMITED Aldhams Farm Research Centre Dead Lane Lawford, Manningtree Essex CO11 2NF AGROCHEMEX LIMITED Aldhams Farm Research Centre Dead Lane Lawford, Manningtree Essex CO11 2NF ALDERLEY ANALYTICAL LIMITED Biohub at Alderley Park Mereside Alderley Park Macclesfield SK10 4TG ALMAC DIAGNOSTIC SERVICES LIMITED 19 Seagoe Industrial Estate Craigavon BT63 5QD ANALYTICAL SERVICES INTERNATIONAL LTD (ASI) Jenner Wing, Level G0 St George's Hospital University of London Cranmer Terrace London SW17 0RE Version 6.0 18 January 2021 ANIMAL AND PLANT HEALTH AGENCY Woodham Lane New Haw Addlestone Surrey KT15 3NB APIS (APPLIED INSECT SCIENCE) Ambrose House Tanfield Lane Wath Ripon HG4 5JE ARC TRINOVA LIMITED T/A ARCINOVA Taylor Drive Alnwick Northumberland NE66 2DH ARCADIS (UK) LIMITED (ARCADIS) 3rd Floor Charter House 62-68 Hills Road Cambridge CB2 1LA ARCTEC London School of Hygeine & Tropical Medicine Keppel Street London WC1E 7HT ARYSTA LIFESCIENCE GREAT BRITAIN LIMITED Brooklands Farm Cheltenham Road Evesham Worcestershire WR11 2LS ASTRAZENECA Address Withheld BATTELLE UK LIMITED 29 Springfield Lyons Approach Springfield Chelmsford CM2 5LB Version 6.0 18 January 2021 BATTELLE UK LIMITED Area 5, Building 1000 Havant Langstone Technology Park Langstone Road, Havant Hants PO9 1SA BAYER CROPSCIENCES UK LTD Address Withheld BIO PRODUCTS LABORATORY Dagger Lane Elstree Hertfordshire WD6 3BX BIOBEST LABORATORIES LIMITED 6 Charles Darwin House Edinburgh Technopole Milton Bridge Penicuik EH26 0PY BIORELIANCE (UK) LIMITED (PENTLANDS SCIENCE PARK) Pentlands Science Park Bush Loan Penicuik EH26 0PZ BIORELIANCE UK LIMITED (GLASGOW) Todd Campus West of Scotland Science Park Strathclyde Glasgow G20 0XA BIORELIANCE UK LIMITED (STIRLING) Stirling University Innovation Park Hillfoots Road Stirling FK9 4NF Version 6.0 18 January 2021 BROUGHTON NICOTINE SERVICES LIMITED Oak Tree House West Craven Business Park West Craven Drive Earby Barnoldswick BB18 6JZ BUTTERWORTH LABORATORIES LIMITED 54-56 Waldegrave Road Teddington Middlesex TW11 8NY CEFAS (CENTRE FOR ENVIRONMENT, FISHERIES & AQUACULTURAL SCIENCE)(LOWESTOFT) Pakefield Road Lowestoft Suffolk NR33 0HT CEFAS (CENTRE FOR ENVIRONMENT, FISHERIES & AQUACULTURAL SCIENCE)(WEYMOUTH) Weymouth Laboratory The Nothe Weymouth Dorset DT4 8UB CEM ANALYTICAL SERVICES LIMITED Imperial House 8 Oaklands Business Centre Oaklands Park Wokingham RG41 2FD CHARLES RIVER LABORATORIES EDINBURGH LIMITED Elphinstone Research Centre Tranent Edinburgh EH33 2NE CHEMEX ENVIRONMENTAL INTERNATIONAL LIMITED Unit J, Broad Lane Cottenham Cambridge CB24 8SW Version 6.0 18 January 2021 CHESHIRE ECO SOLUTIONS 3 Somerset Mews Loch Street Runcorn Cheshire WA7 1LP CONCEPT LIFE SCIENCES ANALYTICAL & DEVELOPMENT SERVICES LIMITED Unit 69 Listerhills Science Park Campus Road Bradford BD7 1HR CONCEPT LIFE SCIENCES, DUNDEE 2 James Lindsay Place Dundee Technopole Dundee DD1 5JJ CONCEPT LIFESCIENCES -SANDWICH Discovery Park House Discovery Park Ramsgate Road Sandwich CT13 9ND COVANCE LABORATORIES LIMITED - HUNTINGDON Woolley Road Alconbury Huntingdon Cambridgeshire PE28 4HS COVANCE LABORATORIES LIMITED - SHARDLOW Shardlow Business Park London Road Shardlow Derbyshire DE72 2GD COVANCE LABORATORIES LIMITED -EYE Occold Eye Suffolk IP23 7PX Version 6.0 18 January 2021 COVANCE LABORATORIES LIMITED Otley Road Harrogate North Yorkshire HG3 1PY DAVID NORRIS ANALYTICAL LABORATORIES LIMITED Unit 12-15-Swan Business Park Sandpit Road Dartford DA1 5ED DEKRA UK LIMITED Phi House Enterprise Road Southampton Science Park Chilworth Southampton SO16 7NS DERMAL TECHNOLOGY LABORATORY LIMITED Med IC 4 Building Keele Science Business Park Keele University Keele Staffordshire ST5 5NL DON WHITLEY SCIENTIFIC LIMITED Victoria Works Victoria Street Bingley West Yorkshire BD16 2NH DRAYTON ANIMAL HEALTH LIMITED Alcester Road Stratford Upon Avon Warwickshire CV37 9RQ EDINBURGH PHARMACEUTICAL PROCESSES LIMITED ENVIRONMENTAL CENTRE Bush Estate Penicuik Midlothian EH26 0PH Version 6.0 18 January 2021 EDINBURGH PHARMACEUTICAL PROCESSES LIMITED Glencorse Building Pentlands Science Park Bush Loan Penicuik Mid Lothian EH26 0PZ EUROFINS AGROSCIENCE SERVICES LTD. Slade Lane Wilson Melbourne Derbyshire DE73 8AG EUROFINS SELCIA LIMITED Fyfield Business and Research Park Fyfield Road Ongar Essex CM5 0GS FERA SCIENCE LIMITED Sand Hutton York North Yorkshire YO41 1LZ FJORDS PROCESSING LIMITED Flotta Stromness Orkney KW16 3NP GEA FARM TECHNOLOGIES (UK) LIMITED Wylye Works Watery Lane Bishoptrow Warminster BA12 9HT GENTRONIX LIMITED Biohub At Alderley Park Mereside Alderley Park Macclesfield SK10 4TG Version 6.0 18 January 2021 GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED Park Road Ware Hertfordshire SG12 0DP HALL ANALYTICAL LABORATORIES LIMITED Unit A Millbrook Business Centre Floats Road Manchester M23 9YJ HISTOLOGIX LIMITED BioCity Pennyfoot Street Nottingham NG1 1GF i2L RESEARCH Capital Business Park Wentloog Cardiff CF3 2PX INFERSTATS CONSULTING LIMITED Biohub At Alderley Park Mereside Alderley Park Macclesfield SK10 4TG INSTITUTE OF AQUACULTURE University of Stirling, Marine Environmental Research Laboratory Machrihanish Campbeltown Argyll PA28 6PZ INTERTEK PHARMACEUTICAL SERVICES MANCHESTER Hexagon Tower P.O. Box 42 Blackley Manchester M9 8ZS Version 6.0 18 January 2021 LGC LIMITED Newmarket Road Fordham Cambridgeshire CB7 5WW LITE (LIVERPOOL INSECT TESTING ESTABLISHMENT) - LIVERPOOL SCHOOL OF TROPICAL MEDICINE 4th Floor Liverpool Life Sciences Accelerator Building 1 Daulby Street Liverpool Merseyside L7 8XZ MAMBO-TOX LIMITED 2 Venture Road University Science Park Chilworth Southampton SO16 7NP MEDPHARM LIMITED Unit 3, Chancellor Court 50 Occam Road Surrey Research Park Guildford Surrey GU2 7AB MOREDUN SCIENTIFIC LIMITED Pentlands Science Park Bush Loan Penicuik Midlothian EH26 0PZ NORBROOK LABORATORIES LIMITED 105 Armagh Road Newry County Down Northern Ireland BT35 6PU NORTHWICK PARK INSTITUTE FOR MEDICAL RESEARCH North West London Hospitals NHS Trust Harrow Middlesex HA1 3UJ Version 6.0 18 January 2021 NUFARM UK LIMITED Wyke Bradford West Yorkshire BD12 9EJ OXFORD AGRICULTURAL TRIALS LIMITED West Farm Barns Launton Road Stratton Audley Bicester Oxon OX27 9AS OXFORD ANALYTICAL A3 Telford Road Bicester Oxon. OX26 4LD OXFORD BIOMEDICA UK LIMITED Windrush Court Transport Way Oxford OX4 6LT PATHCELERATE LIMITED Address Withheld PERFECTUS BIOMED LIMITED Techspace One Keckwick Lane Daresbury Warrington WA4 4AB PHARMARON UK LIMITED Pegasus Way Crown Business Park Rushden Northamptonshire NN10 6ER Version 6.0 18 January 2021 PHARMIDEX PHARMACEUTICAL SERVICES LIMITED Northwick Park Hospital Institute for Medical Research Watford Road Harrow Middlesex HA1 3UJ PRECISION FOR MEDICINE (UK LABS) LIMITED 2 Orchard Road Royston Hertfordshire SG8 5HD PROPATH UK LIMITED Willow Court Netherwood Road Hereford HR2 6JU PUBLIC HEALTH ENGLAND Porton Down Salisbury Wiltshire SP4 0JG QUANTICS CONSULTING LTD Exchange Tower 19 Canning Street Edinburgh EH3 8EH RAMBOLL UK LIMITED 7th Floor, Cornerblock 2 Cornwall Street Birmingham B3 2DX RENASCI LIMITED BioCity Nottingham Pennyfoot Street Nottingham NG1 1GF Version 6.0 18 January 2021 RENTOKIL INITIAL PLC Units A1 & A2 Link 10 Napier Way Crawley West Sussex RH10 9RA REPROCELL EUROPE LIMITED Thomson Pavilion Todd Campus West of Scotland Science Park Acre Road Glasgow G20 0XA RESCHEM ANALYTICAL LIMITED 8 Jubilee Parkway Jubilee Business Park Stores Road Derby DE21 4BJ RIDGEWAY RESEARCH LIMITED Park Farm Buildings Park Lane St Briavels Gloucestershire GL15 6QX ROGER ALISON LTD Address Withheld ROYAL VETERINARY COLLEGE RVC Business Hawkshead Lane North Mymms Hatfield Herts AL9 7TA RPS ENVIRONMENTAL MANAGEMENT LIMITED T/A RPS MOUNTAINHEATH 13 St Martins Way Bedford Bedfordshire MK42 0LF Version 6.0 18 January 2021 RSK ADAS BOXWORTH Battlegate Road Boxworth Cambridge CB23 4NN RSK ADAS GLEADTHORPE Meden Vale Mansfield Nottingham NG20 9PF RXCELERATE LIMITED Babraham Research Campus Maia Building Cambridge CB22 3AT SARTORIOUS STEDIM BIOOUTSOURCE LTD 1 Technology Terrace Todd Campus West of Scotland Science Park Glasgow G20 0XA SCYMARIS LTD Brixham Laboratory Freshwater Quarry Brixham TQ5 8BA SEQUANI LIMITED Bromyard Road Ledbury Hereford HR8 1LH SGS UNITED KINGDOM LIMITED The Chestnut Greatworth Hall Greatworth Banbury Oxon OX17 2DH Version 6.0 18 January 2021 SGS VITROLOGY LIMITED 5 South Avenue Clydebank Business Park Clydebank G81 2LG SMITH & NEPHEW PRECLINICAL SCIENCES 101 Hessle Road Hull HU3 2BN SMITHERS ERS LIMITED 108 Woodfield Drive Harrogate North Yorkshire HG1 4LS STAPHYT LTD 3 Lower Farm Barns Bainton Road Bucknell Nr. Bicester Oxon. OX27 7LT STOCKBRIDGE TECHNOLOGY CENTRE Cawood Selby North Yorkshire YO8 3TZ SURF HISTOLOGY AND IMMUNODETECTION Histology and Imaging Laboratory
Recommended publications
  • Directory of Companies A

    Directory of Companies A

    65 Directory of Companies A An alphabetical list of pharmaceutical companies, as well as manufacturers and suppliers of products and services for Medicinal Chemistry in Europe 3B PHARMACEUTICALS GMBH Magnusstraße 11 12489 BERLIN DE 3M BELGIUM Canadastraat 11, Haven 1005 2070 ZWIJNDRECHT BE 3V-LSI Rubicondreef 18 3561 JC UTRECHT NL of Companies 4SC AG Am Klopferspitz 19a 82152 MARTINSRIED DE A & D INSTRUMENTS LTD Abingdon Science Park OX14 3YX ABINGDON GB ABBVIE DEUTSCHLAND GMBH & CO. KG Knollstrasse 67061 LUDWIGSHAFEN DE Directory ABCR GMBH Im Schlehert 10 76187 Karlsruhe, GERMANY Contact person: Dr. Ute Kiso Tel: +49 721 95061-0 - [email protected] www.abcr.de Gute Chemie. Welcome to abcr. With abcr, you have access to over 260,000 products from the organic, organometallic and inorganic specialty chemicals area. These can be conveniently ordered via our webshop www.abcr.de > Catalogue & Bulk business from grams to tons > Scale up & Commercial manufacturing from our own facility > Sourcing & Logistic management worldwide > Feasibility studies & Synthesis at the laboratory scale > Custom syntheses & Contract Manufacturing ABSORPTION SYSTEMS 440 Creamery Way Suite 300 PA 19341 EXTON US AC IMMUNE SA EPFL Innovation Park Building B 1015 LAUSANNE FR ACCELA CHEMBIO 9823 Pacific Heights Blvd # F 92121 SAN DIEGO US ACRAF S.P.A. Piazzale della Stazione 40 S. PALOMBA - POMEZIA IT ACROS ORGANICS Janssen Pharmaceuticalaan 3a 2440 GEEL BE ACS Journal of Medicinal Chemistry & ACS Medicinal Chemistry Letters Contact person: Janice E. Silverman, Acquisitions Editor Tel: +1 202-577-5975 [email protected] Journal of Medicinal Chemistry – pubs.acs.org/jmc ACS Medicinal Chemistry Letters – pubs.acs.org/acsmedchemlett In 2017 Journal of Medicinal Chemistry is celebrating 60 years of publishing the field’s best peer-reviewed research.
  • Contents Page

    Contents Page

    Statement of Development Principles: Regeneration Of Boots Campus, Beeston, Nottingham June 2007 STATEMENT OF DEVELOPMENT PRINCIPLES: REGENERATION OF BOOTS CAMPUS, BEESTON, NOTTINGHAM (June 2007) Contents 1. Introduction................................................................................................2 PURPOSE.............................................................................................................................. 2 POLICY CONTEXT................................................................................................................ 3 2. Development Principles ............................................................................4 THE VISION........................................................................................................................... 4 KEY DEVELOPMENT PRINCIPLES ..................................................................................... 4 3. Key Issues ..................................................................................................7 HIGHWAYS AND ACCESS ................................................................................................... 7 BALANCE OF USES ............................................................................................................. 7 LISTED BUILDINGS .............................................................................................................. 9 ENVIRONMENT.....................................................................................................................9
  • Acacia Pharma Group

    Acacia Pharma Group

    This document comprises a prospectus (the “Prospectus”) relating to Acacia Pharma Group plc (the “Company” or “Acacia Pharma”) prepared in accordance with the prospectus regulation rules (the “Prospectus Regulation Rules”) of the UK Financial Conduct Authority (the “FCA”) made pursuant to section 73A of the Financial Services and Markets Act 2000, as amended (“FSMA”). This Prospectus has been approved by the FCA as the competent authority under Regulation (EU) 2017/1129 (the “Prospectus Regulation”) and has been filed with and made available to the public in accordance with Rule 3.2 of the Prospectus Regulation Rules. The FCA only approves this Prospectus as meeting the standards of completeness, comprehensibility and consistency imposed by the Prospectus Regulation. Such approval should not be considered as an endorsement of the Company or of the quality of the Ordinary Shares that are the subject of this Prospectus. Investors should make their own assessment as to the suitability of investing in the Ordinary Shares. In addition, this Prospectus has been drawn up as a simplified prospectus in accordance with Article 14 of the Prospectus Regulation. The Belgian Financial Services and Markets Authority (“Belgian FSMA”) was notified of the passporting of this Prospectus in accordance with Article 25 of the Prospectus Regulation. The Company and the Directors, whose names appear on page 39 of this document, accept responsibility for the information contained in this document. To the best of the knowledge of the Company and the Directors, the information contained in this document is in accordance with the facts and this document makes no omission likely to affect its import.
  • A Science and Innovation Audit Report for the Midlands Engine

    A Science and Innovation Audit Report for the Midlands Engine

    A Science and Innovation Audit Report for the Midlands Engine, sponsored by the Department for Business, Energy & Industrial Strategy Volume 1: Main Report 01 November 2016 A Science and Innovation Audit Report for the Midlands Engine, sponsored by the Department for Business, Energy & Industrial Strategy Volume 1: Main Report Contents Midlands Engine SIA – the headlines ....................................................................................1 1. Introduction to the Midlands Engine SIA...........................................................................4 2. SIA ‘hypotheses’ and ‘framework’ ...................................................................................10 3. Regional science and innovation assets and excellence..............................................19 4. Innovation strengths and our growth priorities..............................................................30 5. Market and technology drivers of change.......................................................................53 6. Innovation networks and behaviours ..............................................................................59 7. Next Steps – unlocking our productivity potential.........................................................67 A Science and Innovation Audit Report for the Midlands Engine, sponsored by the Department for Business, Energy & Industrial Strategy Volume 1: Main Report Midlands Engine SIA – the headlines 1. In Autumn 2015 the UK Government announced regional Science and Innovation Audits (SIAs) to catalyse
  • A Preclinical Evaluation of the Discriminative And

    A Preclinical Evaluation of the Discriminative And

    NP5101_proof ■ 12 June 2013 ■ 1/11 Neuropharmacology xxx (2013) 1e11 Contents lists available at SciVerse ScienceDirect Neuropharmacology journal homepage: www.elsevier.com/locate/neuropharm 1 56 2 A preclinical evaluation of the discriminative and reinforcing 57 3 58 4 properties of lisdexamfetamine in comparison to D-amfetamine, 59 5 fi 60 6 methylphenidate and moda nil 61 7 62 a,* a a a b 8 Q5 David J. Heal , Niki W. Buckley , Jane Gosden , Nigel Slater , Charles P. France , 63 9 David Hackett c 64 10 65 a 11 RenaSci Ltd, BioCity Nottingham, Pennyfoot Street, Nottingham NG1 1GF, UK 66 b University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA 12 c Shire Pharmaceutical Development Ltd, Hampshire International Business Park, Chineham, Basingstoke RG24 8EP, Hampshire, UK 67 13 68 14 69 15 article info abstract 70 16 71 17 Article history: Lisdexamfetamine dimesylate, which consists of L-lysine covalently bound to D-amfetamine, is the first 72 18 Received 12 December 2012 prodrug for treating ADHD. Its metabolic conversion to yield D-amfetamine by rate-limited, enzymatic 73 19 Received in revised form hydrolysis is unusual because it is performed by peptidases associated with red blood cells. Other 74 3 April 2013 20 stimulants shown to be effective in managing ADHD include D-amfetamine, methylphenidate and 75 Accepted 13 May 2013 21 modafinil. All have the potential for misuse or recreational abuse. The discriminative and reinforcing 76 effects of these compounds were determined in rats using a 2-choice, D-amfetamine (0.5 mg/kg, i.p.)- 77 22 Keywords: cued drug-discrimination test, and by substitution for intravenous cocaine in self-administration.
  • BIO-SCIENCE FACILITY, LOWER PARLIAMENT STREET, NOTTINGHAM Nottingham City Council Lease the OPPORTUNITY

    BIO-SCIENCE FACILITY, LOWER PARLIAMENT STREET, NOTTINGHAM Nottingham City Council Lease the OPPORTUNITY

    Significant Capital Allowance Investment Opportunity BIO-SCIENCE FACILITY, LOWER PARLIAMENT STREET, NOTTINGHAM Nottingham City Council Lease THE OPPORTUNITY Unique opportunity to acquire a new bio-science incubator facility let on a long lease to a major city council with significant capital allowances providing an attractive post tax return. Prominently located at Lower Parliament Street, Nottingham There are estimated £9,750,000 of available capital allowances to a adjacent to the existing Bio-City buildings within Nottingham’s purchaser which at a higher tax rate of 45% are worth £4,387,500 creative quarter. over a 5 year period. 150 years long-leasehold interest at a peppercorn rent from Nottingham City Council is to provide a loan to the purchaser of Nottingham City Council. £11,011,200 for a 5 years period at a fixed interest rate of 4.50% which equates to £495,484 interest per annum. No amortisation required during this period. Construction commenced in August 2015 on the new Biocity Science building over ground and 4 upper floors providing state of the art laboratory and office accommodation and extending to 52,475 sq ft Purchaser equity requirement of £6,748,800 which after interest NIA. Willmott Dixon is the appointed contractor. charges provides a net annual pre tax yield of 3.18%. To be let to Nottingham City Council for 30 years from completion of this transaction on a full repairing and insuring lease at an initial rent of Post tax annual yields are Year 1 - 7.54%, Year 2 - 6.86%, Year 3 - £714,000 per annum equating to £13.61 per sq ft.
  • Economic Strategy Research Bureau

    Economic Strategy Research Bureau

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Nottingham Trent Institutional Repository (IRep) Biotechnology, life sciences and skills in D2N2: A report for Learn Direct and the D2N2 Local Enterprise Partnership Will Rossiter, David J. Smith, Nikolas Pautz, Daniel McDonald-Junor Economic Strategy Research Bureau Nottingham Business School Nottingham Trent University July 2018 2018 Contents Executive Summary............................................................................................................................ 4 1 Introduction ................................................................................................................................ 6 1.1 Approach ................................................................................................................................. 7 2 What are life sciences and the biotech industry? ....................................................................... 9 2.1 Origins of the Biotechnology industry .................................................................................. 10 2.2 Features of the emerging UK biotechnology industry .......................................................... 13 2.3 The Bioincubator boom of the 2000-2008 ............................................................................ 14 3 Restructuring, Open Innovation and Outsourcing in the Pharmaceutical Industry ................. 17 4 The Decline in Laboratory Technician training ........................................................................
  • Title: the Rise and Rise of Biotech and Life Sciences in Nottingham Will Rossiter, David Smith, & Daniel Mcdonald-Junor

    Title: the Rise and Rise of Biotech and Life Sciences in Nottingham Will Rossiter, David Smith, & Daniel Mcdonald-Junor

    Title: The rise and rise of biotech and life sciences in Nottingham Will Rossiter, David Smith, & Daniel McDonald-Junor, Nottingham Business School Notable in this years’ Top 200 list are an increasing number of local companies involved in the applications of biotechnology and life sciences – companies like Fresenius Medical , Source Bioscience Limited, and Robinsons Healthcare. Indeed this phenomenon has come to symbolise Nottingham’s reinvention as a post-industrial economy. Recent research at Nottingham Business School has started to explain how it happened. At the start of the millennium, Nottingham looked to be a city facing serious industrial decline. Former mainstays of the local economy like Raleigh, Players, and Royal Ordnance had ceased large scale manufacturing operations in the City and employment in the sector continued to shrink as the balance of the economy shifted towards the service sector. Move forward a decade or two however, and you’ll find a different story. A new development path has been forged through the application of biotechnology and life sciences. That this should have happened in a former manufacturing city in the North Midlands is remarkable. The most obvious symbol of this is BioCity, where more than 75 bioscience-related companies have been established since 2003. Although modest in scale by the standards of bioscience concentrations in London and the South East, the emergence of bioscience in Nottingham is significant. Not least because this momentum has been sustained over a 15-year timeframe and shows no signs of slowing. Indeed BioCity is now the country’s largest life science themed business incubation facility.
  • Report Title

    Report Title

    The Midlands Engine Science and Innovation Audit Volume 2: Supporting Annexes 30 September 2016 Science and Innovation Audit Volume 2: Supporting Annexes Contents Annex A: Organisations responding to the e-consultation ................................................. 1 Annex B: Midlands Engine Innovation Group Vision ........................................................... 2 Annex C: Theme-level data ..................................................................................................... 3 Annex D: Thematic workshop notes .................................................................................... 13 Annex E: Further Sci-Val data .............................................................................................. 32 Annex F: Long list of assets ................................................................................................. 46 Annex G: Case examples ...................................................................................................... 68 Annex H: Detailed market priority templates ...................................................................... 78 Annex I: E-consultation responses ...................................................................................... 98 Annex J: Driving competitiveness through our Enabling Competencies ...................... 109 Annex K: Innovation networks and behaviours ............................................................... 112 Science and Innovation Audit Volume 2: Supporting Annexes Annex A: Organisations responding
  • Life Science CLUSTERS the Magazine for Pharmaceutical and Bio-Clusters Spring 2007 • Volume 1 • Number 1

    Life Science CLUSTERS the Magazine for Pharmaceutical and Bio-Clusters Spring 2007 • Volume 1 • Number 1

    Life Science CLUSTERS The magazine for pharmaceutical and bio-clusters Spring 2007 • Volume 1 • Number 1 Cluster Proles on: San Jose, Basel, London, Scotland, Ireland Biotech law companies Super League Biotechnology Clusters – supporting the UK as Europe’s No1 in Bioscience UK Trade & Investment In 1999 the DTI report, “Biotechnology providers with biotechnology personnel London Development Agency has strongly Clusters”, defined ten critical factors in the at focused events, providing a source of committed to the sector by funding the generation of a successful biotechnology local information and mentoring and London Biotechnology Innovation Centre bio cluster in the UK: strong science base; promoting the cluster externally to encourage incubator, which provides space and support entrepreneurial culture; growing company commercial partnering. Increasingly, these for 20 early-stage bioscience enterprises and base; ability to attract key staff; availability networks are associated with bioincubators, has close ties with the London Biotechnology of finance; premises and infrastructure; such as Diagnox in Oxford, BioCity Network (LBN). At over 2,000 members, business support services and large companies Nottingham and CELS in the North East. LBN is one of the largest of its kind in Europe, in related industries; skilled workforce; providing the internationally renowned effective networks and a supportive policy The UK Mega-Cluster BioWednesday event series and the annual environment. Genesis Conference. Cambridge In this article, we will present
  • Delegate List

    Delegate List

    DELEGATE LIST Firstname Surname Job Title Company Aisha Ajij Project Support and Industry Liason Officer East Midlands Academic Health Science Network Ayo Akinduko Fellow University of Leicester Lucy Alexander Head of Research and Enterprise Partnerships Life Science University of Leicester Danielle Allen Marketing Executive TBAT Innovation Peter Anderton TEDx Speaker & Director Internal Alignment Alex Archibald Project Manager Midlands Health Innovation Colin Baker Patent Attorney Potter Clarkson LLP Max Bardwell Strategic Partnership Manager Life Sciences Nottingham Trent University Chris Barker CEO Spirit Healthcare Neil Barnes Project Leader Innovation Medilink East Midlands Yvonne Barnett Board Member Medilink East Midlands Timothy Bates Chief Scientific Officer Drugs With A Difference Limited Pamela Bellis Director WPS (Worldwide Product Sourcing) Ltd Malcolm Bennett Professor of Zoonotic and Emerging Diseases University of Nottingham Jennifer Benson Managing Director WPS (Worldwide Product Sourcing) Ltd Simon Bernard Operations Director Ariane Medical Systems Philippa Bevan Director Accelerate Associates Ian Bolland Web Content Editor Rapid News Group Page 1 of 8 Sarah Bolton Business Manager CHEATA - Centre for Healthcare Equipment and Technology Adoption Chas Bountra Pro-Vice Chancellor for Innovation University of Oxford Katherine Bourne Director Accelerate Associates Julian Bowrey Regional Manager Innovate UK Laura Boyd Deputy Director NHS Innovation Accelerator Raymond Bratty Pain Development Director Orion Pharma Philip Breedon
  • Trade Marks Journal No: 1792, 10/04/2017 P`Kasana : Baart Sarkar Vyaapar Icanh Rijast/I Esa.Ema.Raod Emta^P Ihla Ko Pasa Paos

    Trade Marks Journal No: 1792, 10/04/2017 P`Kasana : Baart Sarkar Vyaapar Icanh Rijast/I Esa.Ema.Raod Emta^P Ihla Ko Pasa Paos

    Trade Marks Journal No: 1792, 10/04/2017 Reg. No. TECH/47-714/MBI/2000 Registered as News Paper p`kaSana : Baart sarkar vyaapar icanh rijasT/I esa.ema.raoD eMTa^p ihla ko pasa paosT Aa^ifsa ko pasa vaDalaa mauMba[- 400037 durBaaYa : 022 24101144 ,24101177 ,24148251 ,24112211. fO@sa : 022 24140808 Published by: The Government of India, Office of The Trade Marks Registry, Baudhik Sampada Bhavan (I.P. Bhavan) Near Antop Hill, Head Post Office, S.M. Road, Mumbai-400037. Tel:022-24140808 1 Trade Marks Journal No: 1792, 10/04/2017 Anauk/maiNaka INDEX AiQakairk saucanaaeM Official Notes vyaapar icanh rijasT/IkrNa kayaa-laya ka AiQakar xao~ Jurisdiction of Offices of the Trade Marks Registry sauiBannata ko baaro maoM rijaYT/ar kao p`arMiBak salaah AaoOr Kaoja ko ilayao inavaodna Preliminary advice by Registrar as to distinctiveness and request for search saMbaw icanh Associated Marks ivaraoQa Opposition ivaiQak p`maaNa p`~ iT.ema.46 pr AnauraoQa Legal Certificate/ Request on Form TM-46 k^apIra[T p`maaNa p`~ Copyright Certificate t%kala kaya- Operation Tatkal saava-jainak saucanaaeM Public Notices svaIkRit ko puva- iva&aipt Aavaodna Applications advertised before acceptance-class-wise: 2 Trade Marks Journal No: 1792, 10/04/2017 vaga- / Class - 1 11-121 vaga- / Class - 2 122-159 vaga- / Class - 3 160-334 vaga- / Class - 4 335-361 vaga- / Class - 5 362-980 vaga- / Class - 6 981-1037 vaga- / Class - 7 1038-1131 vaga- / Class - 8 1132-1154 vaga- / Class - 9 1155-1335 vaga- / Class - 10 1336-1378 vaga- / Class - 11 1379-1481 vaga- / Class - 12 1482-1537